HIV risk behavior in opioid dependent adults seeking detoxification treatment: An exploratory comparison of heroin and oxycodone users

American Journal on Addictions

Volumn 18, Issue 4, 2009, Pages 289-293

  Meade, Christina S ^a,b   McDonald, Leah J ^a   Weiss, Roger D ^a  

^a MCLEAN HOSPITAL   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; DIAMORPHINE; OXYCODONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETOXIFICATION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MENTAL HOSPITAL; OPIATE ADDICTION; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; FEMALE; HEROIN DEPENDENCE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; MALE; MARIJUANA ABUSE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; OXYCODONE; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; RISK-TAKING; SEVERITY OF ILLNESS INDEX; SEXUAL PARTNERS; UNSAFE SEX; YOUNG ADULT;

EID: 67651240800     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490902925821     Document Type: Article

References (30)

1. CDC. HIV/AIDS Surveillance Report, 2006 Atlanta, Ga: U.S. Department of Health and Human Services; 2008.
2. SAMHSA. Heroin: Changes in how it is used, 1995-2005 The DASIS Report Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2007.
3. SAMHSA. Nonmedical use of prescription pain relievers. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2004.
4. SAMHSA. Results from the 2007 National Survey on Drug Use and Health: national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2008.
5. Sullivan LE, Moore BA, Chawarski MC, et al. Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. J Subst Abuse Treat. 2008;35:87-92.
6. Chitwood DD, Griffin DK, Comerford M., et al. Risk factors for HIV-1 seroconversion among injection drug users: a case-control study. Am J Public Health. 1995;85:1538-1542.
7. Miller M, Neaigus A. Sex partner support, drug use and sex risk among HIV-negative non-injecting heroin users. AIDS Care. 2002;14: 801-813.
8. Sánchez J, Comerford M, Chitwood DD, Fernandez MI, Mccoy CB. High risk sexual behaviours among heroin sniffers who have no history of injection drug use: implications for HIV risk reduction. AIDS Care. 2002;14:391-398.
9. Riehman KS, Kral AH, Anderson R, Flynn N, Bluthenthal RN. Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. J Urban Health. 2004;81:249-259.
10. Battjes RJ, Pickens RW, Amsel Z. HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities. Journal of Acquired Immune Deficiency Syndrome. 1991;4:1148-1154.
11. Miller CL, Strathdee SA, Li K, Kerr T, Wood E. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs). Am J Drug Alcohol Abuse. 2007;33:527-536.
12. Des Jarlais DC, Arasteh K, Perlis T, et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS. 2007;21:231-235.
13. Mclellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 1992;9:199-213.
14. Sobell LC, Sobell MB. Timeline followback user's guide: a calendar method for assessing alcohol and drug use. Toronto, Canada: Addiction Research Foundation; 1996.
15. Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90:607-614.
16. Joe GW, Simpson DD. HIV risks, gender, and cocaine use among opiate users. Drug Alcohol Depend. 1995;37:23-28.
17. Camacho LM, Bartholomew NG, Joe GW, Cloud MA, Simpson DD. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug Alcohol Depend. 1996;41:1-7.
18. BakerA,KochanN,DixonJ,WodakA,HeatherN.Drug use and HIV risk-taking behaviour among injecting drug users not currently in treatment in Sydney, Australia. Drug Alcohol Depend. 1994;34:155-160.
19. Brodbeck J, Matter M, Moggi F. Association between cannabis use and sexual risk behavior among young heterosexual adults. AIDS Behav. 2006;10:599-605.
20. Bellis MA, Hughes K, Calafat A, et al. Sexual uses of alcohol and drugs and the associated health risks: a cross sectional study of young people in nine European cities. BMC Public Health. 2008;8:155-166.
21. Woody GE, Donnell D, Seage GR, et al. Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug Alcohol Depend. 1999;53:197-205.
22. Sigmon SC. Characterizing the emerging population of prescription opioid abusers. Am J Addict. 2006;15:208-212.
23. Grau LE, Dasgupta N, Harvey AP, et al. Illicit use of opioids: is OxyContin a "gateway drug"? Am J Addict. 2007;16:166-173.
24. Gordon CM, Forsyth AD, Stall R, Cheever LW. Prevention Interventions With People Living with HIV/AIDS: State of the Science and Future Directions. AIDS Education & Prevention. 2005;17:6-20.
25. Marsch LA, Bickel WK, Badger GJ, Jacobs EA. Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing. Drug Alcohol Depend. 2005;77:195-204.
26. Lott DC, Strain EC, Brooner RK, Bigelow GE, Johnson RE. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate buprenorphine, and methadone. J Subst Abuse Treat. 2006;31:187-194.
27. Semaan S, Des Jarlais DC, Sogolow E, et al. A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Immune Defic Syndr. 2002;30:S73-93.
28. Prendergast ML, Urada D, Podus D. Meta-analysis of HIV risk-reduction interventions within drug abuse treatment programs. J Consult Clin Psychol. 2001;69:389-405.
29. Weinhardt LS, Forsyth AD, Carey MP, Jaworski BC, Durant LE. Reliability and validity of self-report measures of HIV-related sexual behavior: Progress since 1990 and recommendations for research and progress. Arch Sex Behav. 1998;27:155-180.
30. Johnson ME, Fisher DG, I., M., et al. Reliability and validity of not-in-treatment drug users' follow-up self-reports. AIDS Behav. 2000;4:373-380.